Recalls / Class II
Class IIF-2383-2017
Product
Source Naturals Renewal Antioxidant Tablet: 10 Count Sample Pack, 30 Count, 60 Count, & 120 Count per bottle; Ingredient: Maltodextrin, Cellulose (Capsules, Silica and magnesium stearate; 30 count Bottle - Product SN1750: 60 count Bottle - Product SN1751; 120 count Bottle - Product SN1752; 10 Count Sample Packs - Product SN5024. Manufactured for Source Naturals, Santa Cruz, CA
- Type
- Food
- Affected lot / code info
- 30 Count bottles: Lot No. QTY Exp. FG-13852 76 12/15 FG-14726 148 12/15 FG-19274 148 03/16 FG-24304 148 03/16 FG-30636 100 03/16 FG-37569 9 03/16 FG-39616 172 07/17 FG-47423 64 07/17 FG-50614 70 07/17 FG-65266 60 07/17 FG-65266 60 07/17 FG-59256 144 09/18 60 count bottles: Lot No. QTY Exp. FG-13853 338 12/15 FG-14725 468 12/15 FG-19145 290 03/16 FG-23361 206 03/16 FG-23362 396 03/16 FG-34451 98 03/16 FG-38199 38 03/16 FG-39615 424 07/17 FG-50331 122 07/17 FG-53623 144 07/17 FG-59257 362 09/18 FG-65017 206 09/18 120 count bottles: LOT QTY EXP FG-13854 134 12/15 FG-14556 141 12/15 FG-15360 213 12/15 FG-19882 302 03/16 FG-23397 350 03/16 FG-29559 160 03/16 FG-32109 215 03/16 FG-32109 215 03/16 FG-37240 60 03/16 FG-38639 42 03/16 FG-39812 444 07/17 FG-45840 266 07/17 FG-51761 200 07/17 FG-59258 482 09/18 FG-64221 218 09/18 FG-65613 395 09/18; 10 count sample packs; Lot No. QTY Exp. FG-13855 41 12/15 FG-30136 108 03/16 FG-34834 95 03/16 FG-39626 200 07/17 FG-43530 277 07/17 FG-51677 150 07/17 FG-59259 362 09/18
- Quantity
- 9,361 units
Why it was recalled
Dietary supplements contain low levels of undeclared boron
Recalling firm
- Firm
- Threshold Enterprises Ltd
- Notification channel
- Telephone
- Type
- Voluntary: Firm initiated
- Address
- 23 Janis Way, Scotts Valley, California 95066-3506
Distribution
- Distribution pattern
- Nationwide only.
Timeline
- Recall initiated
- 2015-09-11
- FDA classified
- 2017-07-10
- Posted by FDA
- 2017-07-19
- Terminated
- 2017-07-10
- Status
- Terminated
Source: openFDA Food Enforcement endpoint. Recall record F-2383-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings.